Radiogenomics in Aerodigestive Tract Cancers

Plain-language summary

This observational study looked at the relationship between imaging findings and genetic features (radiogenomics) in patients with aerodigestive tract cancers. To join, patients had to be at least 20 years old, with pathologically confirmed cancer and complete staging. It was conducted as a non-phase observational study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Buddhist Tzu Chi General Hospital

Start date

8/1/2020

Estimated completion

12/31/2023

Countries

Taiwan

Related genes

Locations

• Hualien City, Taiwan

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Age at least 20-years
* Pathological proven aerodigestive tract cancers and received complete staging work-up
* Pathological specimen of the primary tumor
* The solid part of the primary tumor should be at least 2 cm for the lung or head and neck cancers. The primary tumor of the esophageal cancer should be at least cT2.

Exclusion Criteria:

* Coexistence of non-aerodigestive tract cancer.
* Only receive best supportive care after diagnosis.
* Unable to comply to FDG PET/CT exam.
* Unable to determine the primary tumor.